CASP1 and metabolic dysfunction-associated steatohepatitis: Baicalin magnesium can improve the disorder of lipid metabolism in NASH rats, reduce hepatic lipid deposition, downregulate the protein and gene expression of TNF-α, NLRP3, caspase-1, IL-18 and IL-1β.